Home
Editorial
Services
Interview
Q&A
Chronicle Specials
PharMart
ePharmail
Archives
Tenders & Project
Tenders & Enquiries
Pharma Projects
Corporate
Company Profiles
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
Join Pharma
|
Login
Home
>
News
you can get e-magazine links on WhatsApp.
Click here
News
Kodiak Sciences enrols first patient in global phase 3 ALTO clinical trial of KSI-501 in patients with diabetic macular edema
,
August 12, 2026
Innate Pharma to advance lacutamab towards phase 3 following partnership with Sobi
,
August 11, 2026
Akeso begins patient dosing in phase II study of TROP2/Nectin-4 bispecific ADC (AK146D1) combined with ivonescimab in breast cancer
,
August 11, 2026
Neurocrine Biosciences begins phase 1 study of NBIP-'1968, a GLP-1/GIP/glucagon receptor triple agonist for obesity
,
August 10, 2026
Fridge-free vaccine shows promise for reaching millions more people worldwide
,
August 10, 2026
Obsidian Therapeutics enrols first patient in phase 1/2 Agni-01 study to evaluate Amsoki-cel in advanced melanoma
,
August 08, 2026
Kodiak Sciences completes enrollment in phase 3 PEAK trial of KSI-101 for macular edema secondary to inflammation
,
August 08, 2026
Dispatch Bio begins patient dosing in phase 1 study of DISP-10, a novel investigational immunotherapy, in advanced gastrointestinal cancers
,
August 08, 2026
Priovant initiates patient enrolment in phase 3 study of brepocitinib in cutaneous sarcoidosis
,
August 08, 2026
Ractigen Therapeutics completes enrollment and first dosing in phase II trial of RAG-17 for SOD1-ALS
,
August 08, 2026
Damora Therapeutics begins phase 1/1b CLARITY-101 trial of DMR-001 in patients with mutant calreticulin-driven essential thrombocythemia and myelofibrosis
,
August 06, 2026
Marvel Biosciences announces positive results from preclinical Fragile X study conducted through the FRAXA Drug Validation Initiative
,
August 06, 2026
4Moving Biotech completes enrollment in phase 2a INFLAM MOTION study evaluating first-in-class intra-articular GLP-1 therapy?targeting synovitis as a driver of pain and disease progression in knee osteoarthritis
,
August 05, 2026
Evexta Bio enters clinical trial collaboration and supply agreement with Roche to evaluate rupitasertib in combo with a SERD in advanced/metastatic breast cancer
,
August 05, 2026
Otsuka unveils unprecedented phase 3 VISIONARY two-year eGFR results demonstrating Voyxact stabilizes kidney function decline to baseline physiologic rate, fundamentally altering disease progression in IgAN
,
August 05, 2026
Keenova Therapeutics announces publication of Xiaflex manuscript in Translational Andrology and Urology
,
August 04, 2026
Invenio Imaging completes enrollment in ON-SITE study, an AI-based image analysis for lung cancer
,
August 04, 2026
AusperBio begins patient dosing in clinical study of AHB-171, a siRNA therapeutic candidate for chronic hepatitis B
,
August 04, 2026
Tiziana Life Sciences announces reduction in brain inflammation in third multiple system atrophy patient treated with intranasal foralumab
,
August 03, 2026
EyePoint completes enrollment of both pivotal phase 3 trials of Duravyu to treat diabetic macular edema
,
August 03, 2026
Results Found:
17160
1
2
3
4
5
Go to
Total Number of Pages:
858
Loading...
Copyright © 2024 Saffron Media Pvt. Ltd |
About us
|
Contact us
|
Advertise
|
Feedback
|
Helpdesk
|
Disclaimer
|
Sitemap
|
Archives
|
Terms & Conditions